Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury. - Wikidata - wikimedia - TriplyDB

Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.

Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q42926298

about

Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway Cytochrome P450 eicosanoids in hypertension and renal disease Vascular actions of 20-HETE Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury.High temporal resolution parametric MRI monitoring of the initial ischemia/reperfusion phase in experimental acute kidney injury.A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.Renal oxygenation in acute renal ischemia-reperfusion injury.20-HETE in acute kidney injury.The circadian clock modulates renal sodium handling.Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury Omega-3 fatty acid supplementation and cardiovascular disease.Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney.Linking non-invasive parametric MRI with invasive physiological measurements (MR-PHYSIOL): towards a hybrid and integrated approach for investigation of acute kidney injury in rats.Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.How bold is blood oxygenation level-dependent (BOLD) magnetic resonance imaging of the kidney? Opportunities, challenges and future directions.Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.The cardioprotection of dihydrotanshinone I against myocardial ischemia-reperfusion injury via inhibition of arachidonic acid ω-hydroxylase.Chemical synthesis and biological evaluation of ω-hydroxy polyunsaturated fatty acids.Liver Graft Susceptibility during Static Cold Storage and Dynamic Machine Perfusion: DCD versus Fatty Livers.A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.Low dose nitrite improves reoxygenation following renal ischemia in rats.Magnetic Resonance Imaging (MRI) Analysis of Ischemia/Reperfusion in Experimental Acute Renal Injury.

P2860

Q28235974-92D0A88C-D89C-4841-A725-59ABA23A3991 Q28252210-95FF7492-922C-48F5-8CD2-2DFA2564AF11 Q28259468-29973A6A-9D1E-48F8-82BF-B8634D106D16 Q28383719-B82BBB69-E8EB-4FC3-B65B-E05A6C619344 Q28397238-4F19CD73-10E4-4E53-80B1-86403597937B Q28398028-2C1F6F41-C81C-4E3A-9B46-2326CE6A4BF1 Q28828865-0DADD84B-1C32-472C-A362-48798BC8EC27 Q33775129-E17EB41C-FA81-4E8C-82DD-016BE1713ADE Q34361800-AF6F5F86-9F30-40E7-A4F6-C16BBEABC388 Q34612094-592B86BF-C360-460B-BA4C-613318B372BA Q35085128-37F84E6E-B0EA-4E6A-81C0-BABDC67AAA49 Q35112037-4FE6101E-E3FF-4302-A63C-D4DFE4B1D37E Q35135211-A6C3C905-C19B-4174-BA51-9238E6897FC2 Q35982363-5B135698-DA57-423B-ACCE-9E7ED49C59C4 Q36104856-EC36A862-AA86-454B-8AC7-F73B2B70855B Q36387184-FFF7FE6E-A609-4CAD-86A2-157FDB7AD805 Q36728865-2DC2AFF0-BE75-4088-AE06-16637C66C613 Q37340856-084FCF28-81D2-4826-A533-E98076DF727B Q37731230-AD3C2B3F-88AE-45B3-B554-4C804EC62207 Q38068579-6B537037-3C67-4877-9EA6-AE0CE61CF101 Q38075585-C2E61274-A4AB-42C7-B245-61AD1E00827C Q38083851-41F78161-7E25-47D8-8EA5-907EF435627D Q38247565-59BFB5AC-DE0A-4E0D-87FE-7767E2C054A1 Q39431317-D22A0D23-CAB6-42C5-BBBD-9FFE32305BA9 Q39435842-F23F6736-51B5-481F-B489-4A58B6AF6F7F Q43965598-7B2D87D2-AC72-4D10-BB7C-9380EF4F202C Q47172365-81F510B1-7921-43F0-AB0A-4EB610D4A5F1 Q47947231-17412945-5EEB-48B2-AB0E-CBA14C209397 Q49966137-40D8D085-AE82-490A-B8DB-6106AFCBF320 Q52859646-EE904E32-002D-4CB2-B1AE-3E19040A3DBD

P2860

Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q42926298

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@en

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@nl

type

label

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@en

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@nl

prefLabel

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@en

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@nl

P1433

Q42926298-D8C34340-5E4A-4ACF-9604-B63351D21AF2

P1476

Q42926298-6B6C9CB8-D38A-47F2-B9AA-7822F28AEF0A

P2093

Q42926298-042969F3-BCF6-4C5D-A5B7-CC7939F598D0

Q42926298-12327917-42A4-4A2A-B2FC-8F8576A3B201

Q42926298-33AB2A52-217C-4A8A-9378-DF9B12942462

Q42926298-3CE48BDD-1B70-47EC-9048-2A86F515EEF7

Q42926298-3FF09270-9413-486B-80B5-0A73F84388C8

Q42926298-4A12B2BE-7C07-4D23-B535-D4D1292F56F8

Q42926298-7A6B805C-0CA8-4B53-A03E-E25A03EB3628

Q42926298-B2B36106-D873-4541-A114-D1864A2CFD1E

Q42926298-C39B39BC-C368-4A3F-A16A-3F5E702E8ADC

Q42926298-C84BE519-00E7-4A66-97C0-53C2B7F87696

P2860

Q42926298-101A4362-E793-4EED-9CA8-77CB11F21D95

Q42926298-16FD1CE8-5028-45B1-9667-4ABD2D00A9BD

Q42926298-17B9A781-1040-45A2-9B8B-75B2111452FF

Q42926298-2313BE9B-5349-421E-B332-4D2E8C1A68AA

Q42926298-245CCEF7-B53B-44CE-B985-EBA4CD8E36A8

Q42926298-37F0A37C-4DA0-4A0E-B6A2-59FF22FE9191

Q42926298-3D38DEC4-FAB3-4E16-A970-E5030F0C5BBD

Q42926298-42FC5778-1906-4966-89B1-FF8669204497

Q42926298-4AE2B1FC-C183-468E-ABE8-3F683E80F4EB

Q42926298-4B769A30-8612-404E-85A2-9500D6CDA5B1

P2888

Q42926298-4502233B-0FC4-4F40-B4BA-9B911C5DD6A7

P304

Q42926298-B674EE01-B15E-4EE8-B380-1CC57DBC4A1A

P31

Q42926298-3C88D833-03DA-458D-B0C0-D95DFE86B23D

P356

Q42926298-35037100-8992-462A-9509-46B2A5B9D0B0

P407

Q42926298-762246D4-DE1E-47AE-8E2E-ECD6CEBAEB8A

P433

Q42926298-AB7F221D-B5FD-4F17-A568-422612A57327

P478

Q42926298-E24E9FD1-6332-4201-AB70-3E64C81BE3C4

P50

Q42926298-09CA21D0-6AB7-4B80-BDE4-0DCC3CBA9337

Q42926298-8F2C3F13-8893-4ABF-84BD-717E20E760A4

Q42926298-A28342BC-9D2E-4669-AE06-7FF56DA0BAC3

Q42926298-A6F0E7FB-659C-4496-9613-1C8309970360

P577

Q42926298-5F22C74D-9665-444A-9E66-4F572A5D3D3B

P698

Q42926298-19842865-2A07-4DE3-93B3-149B36FC98CE

P921

Q42926298-5C6FCA12-06F3-4B34-B65E-E58E4194F1D3

P932

Q42926298-9E40763F-861C-43CB-9615-2807493520B8

P356

P1433

Kidney International

P1476

Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.

@en

P2093

Bert Flemming

http://www.w3.org/2001/XMLSchema#string

Cosima Arnold

http://www.w3.org/2001/XMLSchema#string

Duska Dragun

http://www.w3.org/2001/XMLSchema#string

Erdmann Seeliger

http://www.w3.org/2001/XMLSchema#string

Ivo Lukitsch

http://www.w3.org/2001/XMLSchema#string

Lyubov Chaykovska

http://www.w3.org/2001/XMLSchema#string

Mechthild Ladwig

http://www.w3.org/2001/XMLSchema#string

T Florian Fuller

http://www.w3.org/2001/XMLSchema#string

Uwe Hoff

http://www.w3.org/2001/XMLSchema#string

Vijay L Manthati

http://www.w3.org/2001/XMLSchema#string

P2860

P-450 metabolites of arachidonic acid in the control of cardiovascular function

Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury

20-HETE and the kidney: resolution of old problems and new beginnings.

Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion.

20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.

Microvascular endothelial injury and dysfunction during ischemic acute renal failure.

An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.

Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases.

Ischemic acute renal failure: an inflammatory disease?

ATP-sensitive potassium channels.

P2888

P304

57-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2010.377

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Friedrich C. Luft

Dominik N. Muller

P577

2010-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20962739

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

3813968

http://www.w3.org/2001/XMLSchema#string